Merck asks EU regulator to authorize pill that treats COVID

0 18

Pharmaceutical company Merck has asked the European Medicines Agency to authorize its COVID-19 antiviral treatment

AMSTERDAM — The pharmaceutical company Merck says it has asked the European Medicines Agency to authorize its COVID-19 antiviral treatment, the first pill that has been shown to treat the disease.

In a statement on Monday, Merck said the EU drug regulator had started an expedited licensing process for molnupiravir. If given the green light, it would be the first treatment for COVID-19 that does not need to be administered through needles or intravenous infusions.

Earlier this month, Merck asked the U.S. Food and Drug Administration to OK molnupiravir, and a decision is expected within weeks.

The company reported this month that the pill cut hospitalizations and deaths by half among patients with early symptoms of COVID-19. The results were so strong that independent medical experts monitoring the trial recommended stopping it early.

It would also bolster a two-pronged approach to the pandemic: treatment, by way of medication, and prevention, primarily through vaccinations.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! The News Motion is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment